Functional importance of GLP-1 receptor species and expression levels in cell lines
Authors:
- Lotte Bjerre KnudsenLKLotte Bjerre Knudsen
- Sven HastrupSHSven Hastrup
- Christina Rye UnderwoodCUChristina Rye Underwood
- Birgitte Schjellerup WulffBWBirgitte Schjellerup Wulff
- Jan FlecknerJFJan Fleckner
- 1 April 2012
- journal article
- research article
- Published by Elsevier in Regulatory Peptides
- Vol. 175 (1-3) , 21-29
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Polymorphism and Ligand Dependent Changes in Human Glucagon-Like Peptide-1 Receptor (GLP-1R) Function: Allosteric Rescue of Loss of Function MutationMolecular Pharmacology, 2011
- Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trialThe Lancet, 2010
- Glucagon-like peptide-1 protects mesenteric endothelium from injury during inflammationPeptides, 2009
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)The Lancet, 2009
- GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in MiceDiabetes, 2009
- β-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic β cellsProceedings of the National Academy of Sciences, 2008
- Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell ProliferationJournal of Biological Chemistry, 2008
- Mechanisms of action of glucagon-like peptide 1 in the pancreasPharmacology & Therapeutics, 2007
- Small-molecule agonists for the glucagon-like peptide 1 receptorProceedings of the National Academy of Sciences, 2007
- A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db / db miceProceedings of the National Academy of Sciences, 2007